Colistin Market Set to Hit US$ 510.94 Million by 2034

ha aggiunto una foto Health

2026-11-04 11:05:09 - Translate -

The global colistin market is driven by antimicrobial resistance and the limited availability of effective treatments for severe Gram-negative infections. Intravenous, inhaled, and topical forms serve patients with ventilator-associated pneumonia, bloodstream infections, and urinary tract infections. Tighter controls on livestock use are shifting the market toward human healthcare. Kidney and...

0 Commenti 0 condivisioni 2 Views 0 Anteprima